Home›Research›Compare›ARA-290 vs SS-31
Peptide ComparisonARA-290 vs SS-31
Both are Longevity & Cellular peptides.
ARA-290
Cibinetide
Half-life: ~2 min (IV); ~10–20 min (SC)
16 providers listed
SS-31
Elamipretide
Half-life: ~2-3 hours
50 providers listed
SS-31 carries stronger published evidence (RCT, 11 key studies) than ARA-290 (RCT, 3); both are research compounds.
ARA-290
Evidence
Half-life
~2 min (IV); ~10–20 min (SC)
SS-31
Evidence
Half-life
~2-3 hours
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | SS-31 |
| Less frequent dosing (longer half-life) | SS-31 |
| More provider options (16 vs 50) | SS-31 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
ARA-290
SS-31
ARA-290
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
Cibinetide (ARA 290) reduces small nerve fiber pathology in sarcoidosis patients
ARA 290, a non-hematopoietic erythropoietin analogue, improves metabolic control and neuropathic symptoms in…
SS-31
Protective Effect of Mitochondria-Targeted Polydopamine Nanoparticles in Alleviating Hepatic Ischemia-Reperfu…
Effect of mitochondrial dysfunction on scar formation after spinal cord injury.
Elamipretide (SS-31) promotes recovery by preserving mitochondrial bioenergetics and neural remodeling after…
Targeting Mitochondrial Dysfunction With Elamipretide (SS-31) Improves Skeletal Muscle Performance in a HFpEF…
+7 more
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
About SS-31
Targets cardiolipin in inner mitochondrial membrane; stabilizes cristae structure; enhances electron transport chain efficiency; reduces mitochondrial ROS
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
ARA-290
No established clinical contraindications
SS-31
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
ARA-290
SS-31
Where to source these peptides
ARA-290
16 listed
Browse directory →
Providers offeringSS-31
50 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 22, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). ARA-290 vs SS-31 — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ara-290/ss-31